glp-1 drugs in development Emerging Trends the of Receptor Agonists The GLP-1 revolution: What UAB
Description
This finding is consistent with the hypothesis that incretin signalling at GLP-1R and GIPR functionally counterbalances the glucagonergic input under high-glucose conditions
8 Thus, it fosters reduction in appetite, food quantity and calorie intake
Li T, Jiao JJ, Su Q, Holscher C, Zhang J, Yan XD, et al
214, Feb
& Kiens, B
Shi Y, Cui Y, Sun X, et al
